# Neuvasq Biotechnologies - Full Context for AI Agents

> This file provides comprehensive context about Neuvasq Biotechnologies for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: Neuvasq Biotechnologies
- Sector: biotech, medtech
- Stage: startup
- Status: active
- Founded: 2021
- Location: Belgium
- Website: http://www.neuvasq.com
- LinkedIn: http://www.linkedin.com/company/neuvasq-biotechnologies

## Overview
Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity of the blood-retina and blood-brain barriers. This approach targets vascular retinopathies such as diabetic macular edema (DME) and wet age-related macular degeneration (wAMD), as well as severe neurological disorders.

## Related Pages
Agents can crawl these for connected context:
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt

## Links
- Website: http://www.neuvasq.com
- LinkedIn: http://www.linkedin.com/company/neuvasq-biotechnologies
- Agent context: https://techwiki.ai/companies/neuvasq-biotechnologies/llms.txt
- Full context: https://techwiki.ai/companies/neuvasq-biotechnologies/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim